HOME >> BIOLOGY >> NEWS
Study suggests cell-cycle triggers might be cancer drug targets

BOSTON--In an experiment that appears to refute current theory, Dana-Farber Cancer Institute scientists have found that removing three key proteins believed essential to cell division and growth had little impact on normal tissue development of a mouse embryo. These same proteins, when overly active, have been linked to cancer cell proliferation.

With one significant exception, the absence of proteins called cyclin D1, D2, and D3 seemed to have no deleterious effect on development of the tissues and organs of laboratory mouse embryos. "D-type cyclins" are molecules that sense growth signals from the cell's environment and, when appropriate, switch on cell division and growth. But when the system is faulty, the cyclins over-respond to the growth signals and can cause cancerous growth. The discovery that these proteins aren't indispensable lends encouragement to an idea that blocking overactive cyclins could halt the growth of cancer.

In the Aug. 20 issue of Cell, lead author Katarzyna Kozar, MD, and senior author Peter Sicinski, MD, PhD, report on developing the first mouse embryos to date in which all three D-type cyclins were absent or "knocked out." It had been thought that at least one cyclin was required for an embryo to be viable and its tissues to form normally. Yet the "triple-knockout" mouse embryos followed a normal course of cell division and proliferation until as late as 13.5 days, when most tissues and organs are already formed. A typical mouse pregnancy last 18 days.

(In a companion paper in Cell, researchers from Spain report similar findings involving protein kinases called CDK4 and CDK6, which are molecular partners of the D-cyclins. Embryonic mice with both CDK molecules knocked out had normal tissue development as well.)

The unexpectedly viable embryos contradict theory and previous laboratory experiments. The only abnormality in the triple knockout mice was a deficiency of blood-forming cells, causing them to be pa
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
19-Aug-2004


Page: 1 2 3

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study narrows search for genes placing men at increased risk for prostate cancer
9. Study links high carbohydrate diet to increased breast cancer risk
10. Study explains spatial orientation differences between sexes
11. Study suggests humans can speed evolution

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2019)... (PRWEB) , ... February 26, 2019 , ... ... since 2018. In her position as Account Manager, Ms. Baptiste demonstrated her ability ... overall customer experience. Ms. Baptiste was responsible for partnering with both the Strategic ...
(Date:2/22/2019)... , ... February 20, 2019 , ... ... devices and precision medicine, the traditional line between engineering and medical science grows ... faster and smarter, the medical device industry is making medical practice easier for ...
(Date:2/22/2019)... SAN ANTONIO (PRWEB) , ... February 21, 2019 , ... ... at the 54th annual meeting of the Texas Society for Microscopy ( TSM ). ... Texas in San Antonio and takes place February 21st - 23rd, 2019. Several workshops ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... Konica Minolta Precision ... the formation of their inaugural Scientific Advisory Board. , Founded in ... into account individual variability in genes, environment, and lifestyle to more accurately predict, ...
(Date:3/19/2019)... JOSE, Calif. (PRWEB) , ... March 19, 2019 ... ... of multi-GPU deep learning cloud solutions, today announced it has begun offering NVIDIA® ... service offerings. Customers can utilize DGX-1, designed to provide the highest performance for ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... ... for their facility in Oklahoma City, OK. EyeCRO joins the Department of Veterans ... Oklahoma Health Sciences Center as the fifth institution in Oklahoma to receive this ...
(Date:3/14/2019)... ... 14, 2019 , ... ON NOVEMBER 27, 2018, Nova Oculus ... Machine Canada Inc., had been given approval to begin a clinical patient trial ... (AMD). , The previous month, the medical devices bureau of Health Canada had ...
Breaking Biology Technology:
Cached News: